Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The popularity of GLP-1 receptor agonists for weight management has grown significantly since their clinical effectiveness became widely recognized. Recent surveys indicate that semaglutide prescriptions for weight loss have increased substantially, reflecting a broader shift toward evidence-based metabolic interventions. PlexusDx provides access to compounded semaglutide injections starting at $149 per month, making this therapy available across all 50 states without insurance requirements.
Semaglutide Prescription Growth: What the Numbers Show
Clinical data from major pharmacies and telehealth platforms demonstrates a dramatic increase in semaglutide prescriptions for weight management over the past three years. The medication was originally developed for type 2 diabetes control, but its weight loss benefits led to FDA approval for chronic weight management in 2021. Since then, demand has extended far beyond traditional diabetes care, with estimates suggesting millions of Americans have filled semaglutide prescriptions annually.
The rise reflects both genuine clinical need and increased awareness among patients seeking alternatives to diet-only or surgery-only approaches. Insurance barriers and manufacturing supply constraints initially limited access, leading many patients to seek compounded versions from licensed 503A pharmacies. PlexusDx works with accredited compounding pharmacies to deliver semaglutide injections that meet pharmaceutical standards while offering transparent, flat-rate pricing regardless of dose adjustments.
Why Patients Choose Semaglutide Over Other Weight Loss Options
Semaglutide works by activating GLP-1 receptors in the brain, which regulate hunger signals, appetite control, and blood sugar stability. Unlike older weight loss medications that relied on stimulant effects or metabolism acceleration, semaglutide addresses the neurological pathways that drive overeating and food cravings. Clinical trials have shown that patients using semaglutide achieve sustained weight loss ranging from 10% to 20% of body weight over 68 weeks, with metabolic benefits extending beyond fat loss.
Patient preference also stems from once-weekly dosing convenience and tolerability compared to daily pills or invasive procedures. The medication supports weight loss while maintaining lean muscle mass and improving cardiovascular markers like blood pressure and cholesterol. Accessibility has improved as compounded alternatives from licensed 503A pharmacies have become available, allowing patients to begin treatment without waiting for brand-name shortages or navigating insurance prior authorizations.
Compounded vs. Brand-Name Semaglutide: Access and Affordability
Brand-name semaglutide (Ozempic and Wegovy) initially dominated the market but faced manufacturing delays and insurance coverage limitations that restricted patient access. Compounded semaglutide from licensed 503A pharmacies offers an evidence-based alternative that meets quality and potency standards while reducing costs significantly. PlexusDx sources its semaglutide from accredited 503A compounding pharmacies and offers injections at a flat rate of $149 per month for the first commitment tier, with no flat per-compound pricing changes.
The affordability advantage extends to patients with and without insurance coverage. PlexusDx accepts HSA and FSA funds, making treatment eligible for tax-advantaged health savings accounts. Since no membership fees or insurance requirements exist, patients can access semaglutide therapy directly, eliminating the administrative delays that often prevent timely treatment initiation. The flat-rate pricing model ensures your dose may need to go up as your body responds, but your price won't, providing budget predictability throughout your treatment journey.
Genetic Factors That Influence Semaglutide Response
Not all patients respond equally to semaglutide, and emerging research indicates that genetic variations influence medication effectiveness and side effect tolerance. Key genetic markers such as GLP1R rs6923761 and GIPR rs1800437 affect how efficiently your body's GLP-1 receptors respond to the medication's signaling. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways, 49 peptides, and 150+ genetic insights to predict your personalized response profile.
Understanding your genetic predispositions allows PlexusDx clinicians to optimize your starting dose, anticipate side effect susceptibility, and recommend complementary metabolic supports. The genetic test is available as a $99 add-on after your first month of treatment, enabling informed decision-making about whether semaglutide injection or oral formulations, or alternative compounds like tirzepatide, align best with your genetic metabolism. This precision approach increases the likelihood of meaningful, sustainable weight loss outcomes tailored to your individual biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many people are currently using semaglutide for weight loss?
Estimates suggest millions of Americans have filled semaglutide prescriptions for weight management since 2021, with continued growth as awareness spreads and compounded options improve access. Exact patient numbers vary by source and geography, but pharmacy data indicates semaglutide remains among the top-prescribed weight loss medications across all U.S. states.
Is compounded semaglutide as effective as brand-name Ozempic or Wegovy?
Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient and meets potency standards comparable to brand-name versions. PlexusDx sources all semaglutide from accredited compounding pharmacies, ensuring clinical effectiveness while offering significant cost savings and broader access.
What is the cost of starting semaglutide therapy with PlexusDx?
PlexusDx offers compounded semaglutide injections starting at $149 per month on the first commitment tier, with HSA/FSA eligibility and no insurance requirement. Your dose may need to go up as your body responds, but your price won't, ensuring predictable monthly costs throughout treatment.
What side effects should I expect when starting semaglutide?
Common side effects include nausea, mild vomiting, constipation, or reduced appetite, typically most noticeable during the first two weeks of treatment. Most patients experience symptom improvement as their body adjusts; however, genetic variations detected by the Precision Peptide Genetic Test can help predict individual tolerance and guide dose optimization.
How does the Precision Peptide Genetic Test help with semaglutide treatment?
The $99 genetic test analyzes variants like GLP1R rs6923761 and GIPR rs1800437 across 14 metabolic pathways to reveal your personalized response profile. This information helps PlexusDx clinicians recommend optimal semaglutide dosing, anticipate side effects, and identify whether alternative medications like tirzepatide might work better for your genetic metabolism.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Zepbound Schedule: Understanding When You Can Adjust Your Shot, Including Taking It Two Days Early
Can Wegovy Help With Diabetes? Exploring the Link Between Weight Loss and Blood Sugar